---
title: "ALMS.US (ALMS.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ALMS.US/news.md"
symbol: "ALMS.US"
name: "ALMS.US"
parent: "https://longbridge.com/en/quote/ALMS.US.md"
datetime: "2026-05-20T08:17:13.672Z"
locales:
  - [en](https://longbridge.com/en/quote/ALMS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALMS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALMS.US/news.md)
---

# ALMS.US (ALMS.US) — Related News

### [Sector Update: Healthcare Stocks Softer Friday Afternoon](https://longbridge.com/en/news/286600357.md)
*2026-05-15T17:51:00.000Z*
> Healthcare stocks declined on Friday, with the NYSE Healthcare Index down 0.9%. Aardvark Therapeutics shares plummeted 3

### [This Alumis Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday](https://longbridge.com/en/news/286566238.md)
*2026-05-15T12:28:45.000Z*
> Top analysts have downgraded several stocks, including Tango Therapeutics (from Overweight to Neutral), Viking Holdings 

### [Alumis Q1 Loss Narrows, Revenue Falls; Shares Down Pre-Bell](https://longbridge.com/en/news/286560395.md)
*2026-05-15T11:44:00.000Z*
> Alumis (ALMS) reported a Q1 net loss of $93.1 million, an improvement from a $99 million loss a year prior. Revenue fell

### [Alumis | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 1.741 M](https://longbridge.com/en/news/286501154.md)
*2026-05-15T03:15:38.000Z*
### [Alumis | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 1.741 M](https://longbridge.com/en/news/286464058.md)
*2026-05-14T20:31:51.000Z*
### [Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug](https://longbridge.com/en/news/285837287.md)
*2026-05-10T10:05:16.000Z*
> ACT Capital Management has acquired 174,250 shares of Alumis (NASDAQ:ALMS) for approximately $4.36 million, representing

### [Alumis (ALMS) to Release Quarterly Earnings on Wednesday](https://longbridge.com/en/news/285359319.md)
*2026-05-06T10:47:28.000Z*
> Alumis (NASDAQ:ALMS) is set to release its Q1 2026 earnings on May 13, with analysts predicting a loss of $0.79 per shar

### [Wells Fargo Sticks to Their Buy Rating for Alumis Inc. (ALMS)](https://longbridge.com/en/news/285061728.md)
*2026-05-04T11:06:09.000Z*
> Wells Fargo analyst Derek Archila has reaffirmed a Buy rating for Alumis Inc. (ALMS) with a price target of $49.00. The